SPOTLIGHT -
EP. 1: Multidisciplinary Care in Advanced Pancreatic Cancer
EP. 2: Current Practice With Molecular Testing in Pancreatic Cancer
EP. 3: Metastatic Pancreatic Cancer: Dosing Strategies in the Frontline Setting
EP. 4: Frontline Decisions in Metastatic Pancreatic Cancer
EP. 5: Liposomal Irinotecan in Advanced Pancreatic Cancer
EP. 6: Sequencing Decisions in Advanced Pancreatic Cancer
EP. 7: Advanced Pancreatic Cancer: Quality of Life Considerations
EP. 8: Neoadjuvant Therapy in Locally Advanced Pancreatic Cancer
EP. 9: Ongoing Neoadjuvant Clinical Trials in Pancreatic Cancer
EP. 10: Considerations in Locally Advanced Pancreatic Cancer
EP. 11: Adjuvant Therapy in Pancreatic Cancer
EP. 12: The Potential for Immunotherapy in Pancreatic Cancer
EP. 13: PEGPH20 in Advanced Pancreatic Cancer
EP. 14: Precision Medicine and the Future of Pancreatic Cancer
Dr Berkenstock on ADC-Related Ocular Toxicities in Cervical and Ovarian Cancers
Dr Matalonis on the Management of Mirvetuximab Soravtansine-Related Toxicities in FRα+ Ovarian Cancer
Updated EMPOWER-Lung 3 Data Support Frontline Cemiplimab Plus Chemo in Advanced NSCLC
Neoadjuvant Nivolumab Plus Chemotherapy Retains EFS Advantage in Resectable NSCLC
